Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 2 releases in its history.

Award

14 Jul 2021 at 09:26

Award Notice
Tender

26 Apr 2021 at 10:12

Tender Notice
Summary of the contracting process

The NHS Commissioning Board, operating under the name NHS England, is conducting a public procurement process for the title "NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE". This procurement is classified under the pharmaceutical products category, taking place within the UK. Currently, the procurement is in the Award stage, with a contract that has been signed and is active. The framework agreement has a total maximum duration of 38 months, initiated on 24th June 2021 and due to conclude on 31st January 2023. Interested suppliers must register on the specified eTendering portal by a relevant deadline for participation.

This tender presents significant opportunities for growth, especially for pharmaceutical companies that can provide solutions for health services. Businesses capable of navigating the NHS procurement process and equipped to meet the technical specifications will find this framework advantageous. With the possibility for multiple call-offs throughout the agreement period, suppliers who are agile and innovative in their offerings will particularly benefit in this highly competitive tender.

How relevant is this notice?

Notice Information

Notice Title

NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE

Notice Description

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE region.Offer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)FIND A TENDER (FTS) Reference number: 2021/S 000-008845Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.

Lot Information

Lot 1

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE regionOffer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)Potential periods of call-offs under the framework agreement:24/06/2021 to 31/01/2023 (19 months) LSNE region. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02a9fe
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/016442-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£3,040 Under £100K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
14 Jul 20215 years ago
Submission Deadline
26 May 2021Expired
Future Notice Date
Not specified
Award Date
17 Jun 20215 years ago
Contract Period
24 Jun 2021 - 31 Jan 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
1
Supplier Name

Mylan

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...